266 related articles for article (PubMed ID: 17234761)
1. RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation.
Cammenga J; Niebuhr B; Horn S; Bergholz U; Putz G; Buchholz F; Löhler J; Stocking C
Cancer Res; 2007 Jan; 67(2):537-45. PubMed ID: 17234761
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
3. Gatekeeper function of the RUNX1 transcription factor in acute leukemia.
Niebuhr B; Fischer M; Täger M; Cammenga J; Stocking C
Blood Cells Mol Dis; 2008; 40(2):211-8. PubMed ID: 17920312
[TBL] [Abstract][Full Text] [Related]
4. CBFbeta-SMMHC slows proliferation of primary murine and human myeloid progenitors.
D'Costa J; Chaudhuri S; Civin CI; Friedman AD
Leukemia; 2005 Jun; 19(6):921-9. PubMed ID: 15815715
[TBL] [Abstract][Full Text] [Related]
5. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model.
Fischer M; Schwieger M; Horn S; Niebuhr B; Ford A; Roscher S; Bergholz U; Greaves M; Löhler J; Stocking C
Oncogene; 2005 Nov; 24(51):7579-91. PubMed ID: 16044150
[TBL] [Abstract][Full Text] [Related]
6. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.
Ichikawa M; Asai T; Saito T; Seo S; Yamazaki I; Yamagata T; Mitani K; Chiba S; Ogawa S; Kurokawa M; Hirai H
Nat Med; 2004 Mar; 10(3):299-304. PubMed ID: 14966519
[TBL] [Abstract][Full Text] [Related]
7. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
8. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
[TBL] [Abstract][Full Text] [Related]
9. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.
Yanagida M; Osato M; Yamashita N; Liqun H; Jacob B; Wu F; Cao X; Nakamura T; Yokomizo T; Takahashi S; Yamamoto M; Shigesada K; Ito Y
Oncogene; 2005 Jun; 24(28):4477-85. PubMed ID: 15856017
[TBL] [Abstract][Full Text] [Related]
10. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis.
Pozner A; Lotem J; Xiao C; Goldenberg D; Brenner O; Negreanu V; Levanon D; Groner Y
BMC Dev Biol; 2007 Jul; 7():84. PubMed ID: 17626615
[TBL] [Abstract][Full Text] [Related]
11. Ectopic Runx1 expression rescues Tal-1-deficiency in the generation of primitive and definitive hematopoiesis.
Tornack J; Seiler K; Grützkau A; Grün JR; Onodera M; Melchers F; Tsuneto M
PLoS One; 2013; 8(7):e70116. PubMed ID: 23922928
[TBL] [Abstract][Full Text] [Related]
12. Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta.
Gorczynski MJ; Grembecka J; Zhou Y; Kong Y; Roudaia L; Douvas MG; Newman M; Bielnicka I; Baber G; Corpora T; Shi J; Sridharan M; Lilien R; Donald BR; Speck NA; Brown ML; Bushweller JH
Chem Biol; 2007 Oct; 14(10):1186-97. PubMed ID: 17961830
[TBL] [Abstract][Full Text] [Related]
13. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
Engel ME; Hiebert SW
Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
[TBL] [Abstract][Full Text] [Related]
14. Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult.
Motoda L; Osato M; Yamashita N; Jacob B; Chen LQ; Yanagida M; Ida H; Wee HJ; Sun AX; Taniuchi I; Littman D; Ito Y
Stem Cells; 2007 Dec; 25(12):2976-86. PubMed ID: 17823240
[TBL] [Abstract][Full Text] [Related]
15. Core binding factor in the early avian embryo: cloning of Cbfbeta and combinatorial expression patterns with Runx1.
Bollerot K; Romero S; Dunon D; Jaffredo T
Gene Expr Patterns; 2005 Dec; 6(1):29-39. PubMed ID: 16033710
[TBL] [Abstract][Full Text] [Related]
16. Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells.
Kitoh A; Ono M; Naoe Y; Ohkura N; Yamaguchi T; Yaguchi H; Kitabayashi I; Tsukada T; Nomura T; Miyachi Y; Taniuchi I; Sakaguchi S
Immunity; 2009 Oct; 31(4):609-20. PubMed ID: 19800266
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
19. Increase of hematopoietic progenitor and suppression of endothelial gene expression by Runx1 expression during in vitro ES differentiation.
Sakai E; Kitajima K; Sato A; Nakano T
Exp Hematol; 2009 Mar; 37(3):334-45. PubMed ID: 19218012
[TBL] [Abstract][Full Text] [Related]
20. A 5' untranslated region containing the IRES element in the Runx1 gene is required for angiogenesis, hematopoiesis and leukemogenesis in a knock-in mouse model.
Nagamachi A; Htun PW; Ma F; Miyazaki K; Yamasaki N; Kanno M; Inaba T; Honda Z; Okuda T; Oda H; Tsuji K; Honda H
Dev Biol; 2010 Sep; 345(2):226-36. PubMed ID: 20647008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]